336 related articles for article (PubMed ID: 12490788)
41. Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation.
Abu-Ghosh A; Goldman S; Slone V; van de Ven C; Suen Y; Murphy L; Sender L; Cairo M
Bone Marrow Transplant; 1999 Sep; 24(5):535-44. PubMed ID: 10482939
[TBL] [Abstract][Full Text] [Related]
42. [Immunologic reconstitution of peripheral blood lymphocytes in patients treated by bone marrow transplantation].
Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Otheo E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
Med Clin (Barc); 1996 Feb; 106(5):169-73. PubMed ID: 8684015
[TBL] [Abstract][Full Text] [Related]
43. Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation.
Waller EK; Logan BR; Fei M; Lee SJ; Confer D; Howard A; Chandrakasan S; Anasetti C; Fernando SM; Giver CR
Blood Adv; 2019 Aug; 3(15):2250-2263. PubMed ID: 31345792
[TBL] [Abstract][Full Text] [Related]
44. Post-transplant immune reconstitution after unrelated allogeneic stem cell transplant in patients with acute myeloid leukemia.
Klyuchnikov E; Asenova S; Kern W; Kilinc G; Ayuk F; Wiedemann B; Lioznov M; Freiberger P; Zalyalov Y; Zander AR; Kröger N; Bacher U
Leuk Lymphoma; 2010 Aug; 51(8):1450-63. PubMed ID: 20557144
[TBL] [Abstract][Full Text] [Related]
45. Impact of CMV and EBV on Immune Recovery After Allogeneic Hematopoietic Cell Transplantation in Children.
Pukownik E; Kubicka M; Kurylo-Rafinska B; Debski R; Galazka P; Czyzewski K; Krenska A; Bartoszewicz N; Demidowicz E; Marjańska A; Dziedzic M; Pogorzala M; Wysocki M; Styczynski J
Anticancer Res; 2018 Oct; 38(10):6009-6013. PubMed ID: 30275233
[TBL] [Abstract][Full Text] [Related]
46. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
47. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
[TBL] [Abstract][Full Text] [Related]
48. Reconstitution of lymphocyte subpopulations after hematopoietic stem cell transplantation: comparison of hematologic malignancies and donor types in event-free patients.
Park BG; Park CJ; Jang S; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH
Leuk Res; 2015 Dec; 39(12):1334-41. PubMed ID: 26422556
[TBL] [Abstract][Full Text] [Related]
49. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
50. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome.
Barge RM; Brouwer RE; Beersma MF; Starrenburg CW; Zwinderman AH; Hale G; Waldmann H; den Ottolander GJ; Falkenburg JH; Willemze R; Fibbe WE
Bone Marrow Transplant; 2001 May; 27(10):1053-8. PubMed ID: 11438820
[TBL] [Abstract][Full Text] [Related]
51. Immune reconstitution following allogeneic peripheral blood stem cell transplants.
Shenoy S; Mohanakumar T; Todd G; Westhoff W; Dunnigan K; Adkins DR; Brown RA; DiPersio JF
Bone Marrow Transplant; 1999 Feb; 23(4):335-46. PubMed ID: 10100577
[TBL] [Abstract][Full Text] [Related]
52. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
53. Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantation.
Tayebi H; Tiberghien P; Ferrand C; Lienard A; Duperrier A; Cahn JY; Lapierre V; Saas P; Kuentz M; Blaise D; Hervé P; Robinet E;
Bone Marrow Transplant; 2001 Jan; 27(2):167-75. PubMed ID: 11281386
[TBL] [Abstract][Full Text] [Related]
54. Immune reconstitution in patients with Fanconi anemia after allogeneic bone marrow transplantation.
Perlingeiro Beltrame M; Malvezzi M; Bonfim C; Covas DT; Orfao A; Pasquini R
Cytotherapy; 2014 Jul; 16(7):976-89. PubMed ID: 24831839
[TBL] [Abstract][Full Text] [Related]
55. T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions.
D'Sa S; Peggs K; Pizzey A; Verfuerth S; Thuraisundaram D; Watts M; White H; Hale G; Waldmann H; Goldstone A; Mackinnon S; Yong K
Br J Haematol; 2003 Oct; 123(2):309-22. PubMed ID: 14531914
[TBL] [Abstract][Full Text] [Related]
56. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068
[TBL] [Abstract][Full Text] [Related]
57. Selective CD4+ T-cell depletion does not prevent graft-versus-host disease.
Nagler A; Condiotti R; Nabet C; Naparstek E; Or R; Samuel S; Slavin S
Transplantation; 1998 Jul; 66(1):138-41. PubMed ID: 9679838
[TBL] [Abstract][Full Text] [Related]
58. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
[TBL] [Abstract][Full Text] [Related]
59. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.
Storek J; Dawson MA; Storer B; Stevens-Ayers T; Maloney DG; Marr KA; Witherspoon RP; Bensinger W; Flowers ME; Martin P; Storb R; Appelbaum FR; Boeckh M
Blood; 2001 Jun; 97(11):3380-9. PubMed ID: 11369627
[TBL] [Abstract][Full Text] [Related]
60. Blood versus marrow hematopoietic allogeneic graft.
Robinet E; Lapierre V; Tayebi H; Kuentz M; Blaise D; Tiberghien P
Transfus Apher Sci; 2003 Aug; 29(1):53-9. PubMed ID: 12877895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
